Zymeworks (ZYME) Receivables - Net (2021 - 2026)
Zymeworks recorded quarterly Receivables - Net of $4.7 million in Q1 2026, up 0.78% quarter-over-quarter from $4.6 million in Q4 2025, and down 81.0% year-over-year from $24.6 million in Q1 2025.
Zymeworks' Receivables - Net history runs 6 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Receivables - Net fell 81.0% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (down 81.0% YoY), while the FY2025 annual figure was $4.6 million, down 91.69% from the prior year.
- Receivables - Net came in at $4.7 million for Q1 2026 at Zymeworks, up from $4.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $67.3 million in Q3 2023 to a low of $2.6 million in Q2 2025.
- A 5-year average of $30.1 million and a median of $29.4 million in 2025 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net jumped 899.9% in 2023 and tumbled 91.8% in 2025, its largest moves.
- Zymeworks' Receivables - Net stood at $33.4 million in 2022, then tumbled by 41.69% to $19.5 million in 2023, then jumped by 186.57% to $55.8 million in 2024, then tumbled by 91.69% to $4.6 million in 2025, then gained by 0.78% to $4.7 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $4.7 million, $4.6 million, and $29.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.67 Mn |
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Dec 31, 2023 | 19.48 Mn |
| Dec 31, 2023 | 19.48 Mn |
| Sep 30, 2023 | 67.27 Mn |
| Sep 30, 2023 | 67.27 Mn |
| Jun 30, 2023 | 48.82 Mn |
| Jun 30, 2023 | 48.82 Mn |
| Mar 31, 2023 | 66.92 Mn |
| Mar 31, 2023 | 66.92 Mn |
| Dec 31, 2022 | 33.40 Mn |
| Dec 31, 2022 | 33.40 Mn |
| Sep 30, 2022 | 6.73 Mn |
| Sep 30, 2022 | 6.73 Mn |
| Dec 31, 2021 | 15.61 Mn |
| Dec 31, 2021 | 15.61 Mn |